Silvia, O.; Mazzanti, S.; Gelo Signorino, G.; Pallotta, F.; Ficola, A.; Canovari, B.; Di Muzio, V.; Di Prinzio, M.; Cerutti, E.; Donati, A.;
et al. Ceftazidime–Avibactam in Critically Ill Patients: A Multicenter Observational Study. Antibiotics 2025, 14, 797.
https://doi.org/10.3390/antibiotics14080797
AMA Style
Silvia O, Mazzanti S, Gelo Signorino G, Pallotta F, Ficola A, Canovari B, Di Muzio V, Di Prinzio M, Cerutti E, Donati A,
et al. Ceftazidime–Avibactam in Critically Ill Patients: A Multicenter Observational Study. Antibiotics. 2025; 14(8):797.
https://doi.org/10.3390/antibiotics14080797
Chicago/Turabian Style
Silvia, Olivieri, Sara Mazzanti, Gabriele Gelo Signorino, Francesco Pallotta, Andrea Ficola, Benedetta Canovari, Vanessa Di Muzio, Michele Di Prinzio, Elisabetta Cerutti, Abele Donati,
and et al. 2025. "Ceftazidime–Avibactam in Critically Ill Patients: A Multicenter Observational Study" Antibiotics 14, no. 8: 797.
https://doi.org/10.3390/antibiotics14080797
APA Style
Silvia, O., Mazzanti, S., Gelo Signorino, G., Pallotta, F., Ficola, A., Canovari, B., Di Muzio, V., Di Prinzio, M., Cerutti, E., Donati, A., Giacometti, A., Barchiesi, F., & Brescini, L.
(2025). Ceftazidime–Avibactam in Critically Ill Patients: A Multicenter Observational Study. Antibiotics, 14(8), 797.
https://doi.org/10.3390/antibiotics14080797